← Eichor
Study identifier: NCT06354790 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Natural History Study of Children With LAMA2-related Dystrophies

Condition: Merosin Deficient Congenital Muscular Dystrophy  ·  Sponsor: Institut de Myologie, France

PhaseN/A
Planned participants40
Who can joinAll sexes, 2 Years to 15 Years
Healthy volunteersNo

About this study

The goal of this natural history study is to characterize the disease course, characteristics in paediatric population of LAMA2-RD (related dystrophies) patients. The aim of the study is to establish a well-described cohort of patients in France with LAMA2-RD for prospective follow-up and recruitment for future clinical trials. Participants will be follow up during a two years period regarding exhaustive aspects of the pathology: * Muscular function * Respiratory function * Cognitive phenotyping * Quality of life * Growth parameters * Biomarkers

This description comes directly from the study's public registry record.

Talk to the study team

Andreea SEFERIAN, Dr  ·  +33 (0)1 71 73 80 50  ·  a.seferian@institut-myologie.org

Erwan GASNIER, PhD

Always discuss trial participation with your own doctor first.

Locations (4)

Centre de Référence GNMH, Pédiatrie Hôpital Raymond-PoincaréGarches, FranceNot Yet Recruiting
Service de MPR pédiatrique L'Escale - HCLLyon, FranceNot Yet Recruiting
Département de neuropédiatrie Pôle Femme Mère Enfant CHU de Montpellier - Hôpital Gui de ChauliacMontpellier, FranceNot Yet Recruiting
Plateforme d'essais cliniques pédiatriques iMotionParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06354790